TELA Bio (TELA) Total Non-Current Liabilities (2018 - 2026)

TELA Bio's Total Non-Current Liabilities history runs 9 years deep, the most recent figure standing at $73.7 million for Q1 2026.

• On a quarterly basis, Total Non-Current Liabilities rose 27.48% year-over-year to $73.7 million in Q1 2026; TTM through Mar 2026 was $73.7 million, a 27.48% increase from a year earlier, with the FY2025 full-year figure at $73.6 million, up 29.81% from the prior year.
• Total Non-Current Liabilities steadied at $73.7 million in Q1 2026 per TELA's latest filing, from $73.6 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $73.7 million in Q1 2026 and bottomed at $44.0 million in Q1 2022.
• The 5-year median for Total Non-Current Liabilities is $55.8 million (2024), against an average of $57.1 million.
• Across the five-year window, Total Non-Current Liabilities jumped 35.11% in 2022 and declined 1.32% in 2024, its largest moves.
• Year by year, Total Non-Current Liabilities stood at $52.3 million in 2022, then climbed by 9.87% to $57.5 million in 2023, then retreated by 1.32% to $56.7 million in 2024, then gained by 29.81% to $73.6 million in 2025, then increased by 0.1% to $73.7 million in 2026.
• Per Business Quant, the three latest TELA Total Non-Current Liabilities figures stand at $73.7 million (Q1 2026), $73.6 million (Q4 2025), and $58.5 million (Q3 2025).